May 7, 2020 / 9:56 PM / a month ago

BRIEF-Novabay Pharmaceuticals Reports First Quarter 2020 Financial Results

May 7 (Reuters) - NovaBay Pharmaceuticals Inc:

* NOVABAY PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.06

* EMERGENCY USE APPROVAL FOR COVID-19 TEST KITS FILED ON APRIL 17, 2020

* QTRLY NET PRODUCT REVENUE OF $1.9 MILLION, UP 30% YEAR-OVER-YEAR

* ARE NEARING MILESTONE OF SELLING ONE MILLION KN95 MASKS

* REPORTED CASH AND CASH EQUIVALENTS OF $5.7 MILLION AS OF MARCH 31, 2020, COMPARED WITH $6.9 MILLION AS OF DECEMBER 31, 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below